Clinical Trials · NCT07772960

Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes

Name: Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 1Semaglutide

Phase: Phase 1
Recruitment status: Not Yet Recruiting
Sponsor: Yale University
Enrollment: 90
Start date: Oct 2026
Locations: 1 site, United States
Primary endpoint: Alcohol use days

View Semaglutide compound reference